Treatment of ocular toxoplasmosis with clindamycin and sulfadiazine

K. F. Tabbara, G. R. O'Connor

Research output: Contribution to journalArticle

Abstract

Seventeen patients with active toxoplasmic retinochoroiditis were treated for four weeks, seven with clindamycin alone and ten with a combination of clindamycin and sulfadiazine. The follow-up period ranged from 6 months to four years. Results of the Sabin-Feldman dye test were positive in all patients. Five of the seven patients treated with clindamycin alone showed improvement two weeks after treatment was begun, while eight of the ten patients treated with combined clindamycin and sulfadiazine showed both subjective and objective improvement within ten days and signs of healing within three weeks. Since clindamycin and sulfadiazine operate on unrelated metabolic pathways of Toxoplasma, they may act synergistically. A regimen consisting of this combination may be appropriate for the treatment of ocular toxoplasmosis.

Original languageEnglish (US)
Pages (from-to)129-134
Number of pages6
JournalOphthalmology
Volume87
Issue number2
StatePublished - 1980
Externally publishedYes

Fingerprint

Ocular Toxoplasmosis
Sulfadiazine
Clindamycin
Therapeutics
Toxoplasma
Metabolic Networks and Pathways
Coloring Agents

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Tabbara, K. F., & O'Connor, G. R. (1980). Treatment of ocular toxoplasmosis with clindamycin and sulfadiazine. Ophthalmology, 87(2), 129-134.

Treatment of ocular toxoplasmosis with clindamycin and sulfadiazine. / Tabbara, K. F.; O'Connor, G. R.

In: Ophthalmology, Vol. 87, No. 2, 1980, p. 129-134.

Research output: Contribution to journalArticle

Tabbara, KF & O'Connor, GR 1980, 'Treatment of ocular toxoplasmosis with clindamycin and sulfadiazine', Ophthalmology, vol. 87, no. 2, pp. 129-134.
Tabbara, K. F. ; O'Connor, G. R. / Treatment of ocular toxoplasmosis with clindamycin and sulfadiazine. In: Ophthalmology. 1980 ; Vol. 87, No. 2. pp. 129-134.
@article{225a915c3d934de4b19f26c3fc8c8ed1,
title = "Treatment of ocular toxoplasmosis with clindamycin and sulfadiazine",
abstract = "Seventeen patients with active toxoplasmic retinochoroiditis were treated for four weeks, seven with clindamycin alone and ten with a combination of clindamycin and sulfadiazine. The follow-up period ranged from 6 months to four years. Results of the Sabin-Feldman dye test were positive in all patients. Five of the seven patients treated with clindamycin alone showed improvement two weeks after treatment was begun, while eight of the ten patients treated with combined clindamycin and sulfadiazine showed both subjective and objective improvement within ten days and signs of healing within three weeks. Since clindamycin and sulfadiazine operate on unrelated metabolic pathways of Toxoplasma, they may act synergistically. A regimen consisting of this combination may be appropriate for the treatment of ocular toxoplasmosis.",
author = "Tabbara, {K. F.} and O'Connor, {G. R.}",
year = "1980",
language = "English (US)",
volume = "87",
pages = "129--134",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Treatment of ocular toxoplasmosis with clindamycin and sulfadiazine

AU - Tabbara, K. F.

AU - O'Connor, G. R.

PY - 1980

Y1 - 1980

N2 - Seventeen patients with active toxoplasmic retinochoroiditis were treated for four weeks, seven with clindamycin alone and ten with a combination of clindamycin and sulfadiazine. The follow-up period ranged from 6 months to four years. Results of the Sabin-Feldman dye test were positive in all patients. Five of the seven patients treated with clindamycin alone showed improvement two weeks after treatment was begun, while eight of the ten patients treated with combined clindamycin and sulfadiazine showed both subjective and objective improvement within ten days and signs of healing within three weeks. Since clindamycin and sulfadiazine operate on unrelated metabolic pathways of Toxoplasma, they may act synergistically. A regimen consisting of this combination may be appropriate for the treatment of ocular toxoplasmosis.

AB - Seventeen patients with active toxoplasmic retinochoroiditis were treated for four weeks, seven with clindamycin alone and ten with a combination of clindamycin and sulfadiazine. The follow-up period ranged from 6 months to four years. Results of the Sabin-Feldman dye test were positive in all patients. Five of the seven patients treated with clindamycin alone showed improvement two weeks after treatment was begun, while eight of the ten patients treated with combined clindamycin and sulfadiazine showed both subjective and objective improvement within ten days and signs of healing within three weeks. Since clindamycin and sulfadiazine operate on unrelated metabolic pathways of Toxoplasma, they may act synergistically. A regimen consisting of this combination may be appropriate for the treatment of ocular toxoplasmosis.

UR - http://www.scopus.com/inward/record.url?scp=0018836469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018836469&partnerID=8YFLogxK

M3 - Article

C2 - 7383542

AN - SCOPUS:0018836469

VL - 87

SP - 129

EP - 134

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 2

ER -